CPRX vs ZTS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
CPRX
ZTS
Investment Advisor Scores
ZTS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CPRX | ZTS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.9534 | 11.9904 | ZTS |
| PEG Ratio | 0 | 6.6639 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.6% | -0.2% | CPRX |
| Earnings Growth | 11.1% | 1.2% | CPRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.8/100 | 26.3/100 | CPRX |
| Profit Margin | 37.1% | 27.7% | CPRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | CPRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CPRX
MarkupPrice above SMA50, rising 50-day trend (6.9% over 20 days), RSI 71
ZTS
NeutralMixed signals - no dominant trend phase, RSI 74
Fundamentals Snapshot
| Metric | CPRX | ZTS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.9 | 12.2 |
| Trailing P/E | 18.2 | 13.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.8% | 0.7% |
| Operating Margin | 0.5% | 0.4% |
| EPS | 1.73 | 6.08 |
| Dividend Yield | — | 0.03% |